Bukwang Pharmaceutical Pursues Structural Overhaul Through Rights Offering
Bukwang Pharmaceutical which returned to profitability last year, has launched a rights offering to push ahead with a…
Bukwang Pharmaceutical
2 개의 기사가 있습니다.
Bukwang's Performance Declines Over 2.5 Years Under OCI: Will Q3 Bring a Turnaround?
It's been two and a half years since OCI became the largest shareholder of Bukwang Pharmaceutical, yet instead…